{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T17:02:40Z","timestamp":1781715760434,"version":"3.54.5"},"reference-count":16,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.transproceed.2012.10.024","type":"journal-article","created":{"date-parts":[[2013,1,31]],"date-time":"2013-01-31T14:35:39Z","timestamp":1359642939000},"page":"115-118","source":"Crossref","is-referenced-by-count":8,"title":["Renal Transplantation Between Siblings With Unrecognized Fabry Disease"],"prefix":"10.1016","volume":"45","author":[{"given":"S.","family":"Taneda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Honda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Huchinoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Oda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2012.10.024_bib1","first-page":"113","article-title":"Fabry disease: molecular genetics of the inherited nephropathy","volume":"18","author":"Desnick","year":"1989","journal-title":"Adv Nephrol Necker Hosp"},{"issue":"suppl 2","key":"10.1016\/j.transproceed.2012.10.024_bib2","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1023\/A:1012423924648","article-title":"Renal pathological changes in Fabry disease","author":"Sessa","year":"2001","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.transproceed.2012.10.024_bib3","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/ki.1978.32","article-title":"Early renal changes in hemizygous and heterozygous patients with Fabry's disease","volume":"13","author":"Gubler","year":"1978","journal-title":"Kidney Int"},{"key":"10.1016\/j.transproceed.2012.10.024_bib4","series-title":"Heptinstall's pathology of the kidney","author":"Finn","year":"2007"},{"key":"10.1016\/j.transproceed.2012.10.024_bib5","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1056\/NEJM199508033330504","article-title":"An atypical variant of Fabry's disease in men with left ventricular hypertrophy","volume":"333","author":"Nakao","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transproceed.2012.10.024_bib6","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1046\/j.1523-1755.2003.00160.x","article-title":"Fabry disease: detection of undiagnosed hemodialysis patients and identification of a \u201crenal variant\u201d phenotype","volume":"64","author":"Nakao","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.transproceed.2012.10.024_bib7","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1001\/jama.285.21.2743","article-title":"Enzyme replacement therapy in Fabry disease: a randomized controlled trial","volume":"285","author":"Schiffmann","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.transproceed.2012.10.024_bib8","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1056\/NEJM197102042840503","article-title":"Ceramide trihexosidosis (Fabry's disease) without skin lesions","volume":"284","author":"Clarke","year":"1971","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transproceed.2012.10.024_bib9","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1097\/00007890-200006150-00033","article-title":"Mycophenolate mofetil reduces late renal allograft loss independent of acute rejection","volume":"69","author":"Ojo","year":"2000","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2012.10.024_bib10","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/0167-5273(85)90179-2","article-title":"Progressive cardiac involvement by Fabry's disease despite successful renal allotransplantation","volume":"7","author":"Kramer","year":"1985","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.transproceed.2012.10.024_bib11","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1272\/jnms.72.254","article-title":"Cardiovascular manifestations of Fabry disease and the novel therapeutic strategies","volume":"72","author":"Seino","year":"2005","journal-title":"J Nippon Med Sch"},{"key":"10.1016\/j.transproceed.2012.10.024_bib12","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1023\/B:BOLI.0000005658.14563.77","article-title":"Enzyme replacement therapy in heterozygous females with Fabry disease: results of a phase IIIB study","volume":"26","author":"Baehner","year":"2003","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.transproceed.2012.10.024_bib13","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJM200107053450102","article-title":"Safety and efficacy of recombinant human alpha-galactosidase A\u2013replacement therapy in Fabry's disease","volume":"345","author":"Eng","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transproceed.2012.10.024_bib14","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/ndt\/18.1.33","article-title":"Enzyme replacement therapy in Anderson-Fabry's disease: beneficial clinical effect on vital organ function","volume":"18","author":"De Schoenmakere","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.transproceed.2012.10.024_bib15","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1111\/j.1523-1755.2004.00514.x","article-title":"Enzyme replacement therapy with agalsidase beta in kidney transplant patients with Fabry disease: a pilot study","volume":"65","author":"Mignani","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.transproceed.2012.10.024_bib16","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1046\/j.1523-1755.2002.00675.x","article-title":"Globotriaosylceramide accumulation in the Fabry kidney is cleared from multiple cell types after enzyme replacement therapy","volume":"62","author":"Thurberg","year":"2002","journal-title":"Kidney Int"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134512012377?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134512012377?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,18]],"date-time":"2018-10-18T22:31:32Z","timestamp":1539901892000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134512012377"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S0041134512012377"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2012.10.024","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}